Brooks Laboratories Q3FY22 consolidated loss at Rs. 7.75 crores

Brooks Laboratories Limited has reported Consolidated financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 19.3763 crores during the period ended December 31, 2021 as compared to Rs. 21.5678 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. -7.7538 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. -4.8307 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. -3.16 for the period ended December 31, 2021 as compared to Rs. -1.97 for the period ended September 30, 2021.

Financials	Q3 FY2022	Q2 FY2022	% Change
Total Income	₹ 19.3763 crs	₹21.5678 crs	-10.16%
Net Profit	₹-7.7538 crs	₹-4.8307 crs	60.51%
EPS	₹-3.16	₹-1.97	60.41%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs. 19.3763 crores during the period ended December 31, 2021 as compared to Rs.20.9632 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.-7.7538 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.-2.5550 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.-3.16 for the period ended December 31, 2021 as compared to Rs.-1.05 for the period ended December 31, 2020.

Financials	Q3 FY2022	Q3 FY2021	% Change
Total Income	₹ 19.3763 crs	₹20.9632 crs	-7.57%
Net Profit	₹-7.7538 crs	₹-2.5550 crs	203.48%
EPS	₹-3.16	₹-1.05	200.95%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.63.3414 crores during the 9 Months period ended December 31, 2021 as compared to Rs.63.3077 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.-12.5845 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.-2.0766 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.-5.13 for the 9 Months period ended December 31, 2021 as compared to Rs.-0.87 for the 9 Months period ended December 31, 2020.

Financials	9 Months Ended FY2022	9 Months Ended FY2021	% Change
Total Income	₹63.3414 crs	₹63.3077 crs	0.05%
Net Profit	₹-12.5845 crs	₹-2.0766 crs	506.01%
EPS	₹-5.13	₹-0.87	489.66%

Shares of Brooks Laboratories Limited was last trading in BSE at Rs. 93.45 as compared to the previous close of Rs. 94.15. The total number of shares traded during the day was 345 in over 11 trades.

The stock hit an intraday high of Rs. 94.55 and intraday low of 92.75. The net turnover during the day was Rs. 32561.00.

Source : Equity Bulls

Keywords

BrooksLaboratories Q3FY22 9MFY22 ResultUpdate